Oklahoma · 2026 Regular Session
Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.
Second Reading referred to Health and Human Services Committee then to Appropriations Committee (2025-04-01)